What symptoms are associated with decreased blood flow velocity in the basilar artery?

The basilar artery is an unpaired artery formed by the confluence of the two vertebral arteries. Within the skull, it courses along the ventral surface of the pons and bifurcates into the two posterior cerebral arteries, supplying blood to the pons, cerebellum, posterior portion of the cerebrum, and inner ear. A reduction in basilar artery blood flow velocity poses significant clinical risks, leading to diminished quality of life and triggering various uncomfortable symptoms. So, what symptoms are associated with decreased basilar artery blood flow velocity? The following section addresses this question.

Symptoms of Decreased Basilar Artery Blood Flow Velocity

A decrease in basilar artery blood flow velocity essentially reflects posterior circulation ischemia. When blood flow velocity declines to a critical level—sufficiently compromising perfusion to the brainstem—patients may develop severe symptoms, including dizziness, episodic vertigo (a sensation of spinning), nausea, and vomiting. In more serious cases, transient neurological deficits may occur, such as numbness or weakness in the limbs. This reduced flow velocity is commonly attributable to atherosclerosis, diminished vascular elasticity, accumulation of abnormal blood components, or formation of atherosclerotic plaques on the arterial wall. Treatment typically includes oral administration of medications that improve cerebral circulation. Additionally, patients with decreased basilar artery flow velocity require close monitoring of serum lipid and glucose levels.

Knowledge Extension: Management of Decreased Basilar Artery Blood Flow Velocity

1. Patients should prioritize adequate rest, avoid tobacco and alcohol, refrain from staying up late or overexerting themselves, and follow their physician’s guidance for pharmacological treatment. Commonly prescribed medications include aspirin and Xuesaitong soft capsules. For patients experiencing severe dizziness, medications such as flunarizine (Sibelium®) or betahistine (Meniex® or Serc®) may be administered, all of which demonstrate satisfactory therapeutic efficacy.

2. During medication therapy, dietary habits require special attention: patients should consume foods rich in high-quality protein and vitamins, while maintaining a low-salt, low-sugar, and low-fat diet. Intake of animal fats and sweets should be avoided. Furthermore, patients should maintain a positive mental outlook, as psychological well-being serves as an important adjunct to treatment. Regular, moderate physical exercise is also recommended to enhance immune function and promote overall recovery.

The above outlines the symptoms associated with decreased basilar artery blood flow velocity. We hope this information proves helpful to you.